Fatty Liver Disease and Medical Weight Loss
Metabolic fatty liver disease is common in people with obesity or type 2 diabetes, but liver fat and liver scarring are not the same. Risk assessment may require primary-care or specialist coordination.
Weight loss is only part of care
Laboratory tests and noninvasive fibrosis assessment may be appropriate. Patients with suspected advanced fibrosis, abnormal liver tests or other liver risks may need hepatology evaluation. Alcohol and all medications or supplements should be reviewed.
How W8MD can help
W8MD considers the condition in the context of weight history, current medicines, nutrition, sleep, physical ability, prior attempts, preferences, coverage and cost. Treatment may include lifestyle care, medical nutrition support, prescription options and related sleep evaluation when appropriate.
Care coordination
W8MD weight management complements rather than replaces primary care or specialist treatment. Laboratory tests are individualized. Patients should not independently reduce glucose, blood-pressure, psychiatric, thyroid or other medicines as weight or food intake changes.
Request a W8MD evaluation
Brooklyn: 718-946-5500 · Northeast Philadelphia: 215-676-2334
Calling is fastest. Use the form only for a non-urgent callback request and do not submit private medical, insurance, financial or other sensitive information.
Medical notice: Educational information only. The first visit is in person. W8MD does not promise a diagnosis, test, prescription, insurance approval or result. Medication changes must be coordinated with the responsible clinician. Call 911 for an emergency.
Content reviewed for general accuracy by W8MD clinical leadership. Last reviewed September 2026.